Nautilus Biotechnology, Inc. (NAUT) Capital expenditures 2020–2025
Nautilus Biotechnology, Inc. (NAUT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.3MFY2025 · since FY2020: $921,000 → $1.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3M | -39.8% |
| FY2024 | $2.1M | -13.1% |
| FY2023 | $2.4M | +5.1% |
| FY2022 | $2.3M | +2.4% |
| FY2021 | $2.3M | +146.4% |
| FY2020 | $921,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice